MedWellAI increases authorized Series B Convertible Preferred Stock from 1M to 1.5M shares

MedWellAI, Inc.

Filed Certificate of Amendment with Nevada Secretary of State on April 16, 2026.
Authorized Series B Convertible Preferred Stock increased from 1,000,000 to 1,500,000 shares.
Other terms of the Series B Certificate of Designation remain unchanged.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MedWellAI, Inc.: Increased authorized shares of Series B Convertible Preferred Stock from 1,000,000 to 1,500,000 (effective 2026-04-16).

Change: charter amendment
Effective: 2026-04-16

Exact text from the filing

On April 16, 2026, MedWellAI, Inc. (the “ Company ”) filed a Certificate of Amendment to the Certificate of Designation, Preferences and Rights of Series B Convertible Preferred Stock of the Company (the “ Certificate of Amendment ”) with the Secretary of State of the State of Nevada.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

MedWellAI, Inc. filing history →

Source: SEC EDGAR

accession 0001477932-26-002361

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.